CTAD taskforce: genetic therapies in Alzheimer's disease.
Saved in:
| Title: | CTAD taskforce: genetic therapies in Alzheimer's disease. |
|---|---|
| Authors: | Jakabek D; University College London, London, UK., Isaacs AM; University College London, London, UK., De Strooper B; UKDRI@ University College London, London, UK and VIB@KULeuven, Belgium., Tuszynski M; University of California San Diego, San Diego, USA., Lane R; IONIS Pharmaceuticals, Carlsbad, USA., Uspenskaya O; Prevail Therapeutics, a wholly-owned subsidiary of Eli Lilly and Company, USA., McDade E; Washington University in St. Louis, Saint Louis, USA., Rafii MS; University of Southern California, Los Angeles, USA., Mummery CJ; University College London, London, UK. Electronic address: cath.mummery@nhs.net. |
| Source: | The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Sep; Vol. 12 (8), pp. 100269. Date of Electronic Publication: 2025 Jul 09. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2426-0266 |
|---|---|
| DOI: | 10.1016/j.tjpad.2025.100269 |
